MRBPX
Price
$23.33
Change
+$0.10 (+0.43%)
Updated
Jan 30 closing price
Net Assets
1.64B
RLEFX
Price
$35.37
Change
+$0.24 (+0.68%)
Updated
Jan 30 closing price
Net Assets
241.03B
Ad is loading...

MRBPX vs RLEFX

Header iconMRBPX vs RLEFX Comparison
Open Charts MRBPX vs RLEFXBanner chart's image
BlackRock Sustainable Balanced R
Price$23.33
Change+$0.10 (+0.43%)
VolumeN/A
Net Assets1.64B
American Funds American Balanced R5E
Price$35.37
Change+$0.24 (+0.68%)
VolumeN/A
Net Assets241.03B
MRBPX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MRBPX vs. RLEFX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRBPX is a StrongBuy and RLEFX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 241B vs. MRBPX (1.64B). RLEFX (2.42) and MRBPX (2.31) have matching dividends . MRBPX was incepted earlier than RLEFX: MRBPX (22 years) vs RLEFX (9 years). RLEFX is a more actively managed with annual turnover of: 171.00 vs. MRBPX (152.00). MRBPX has a lower initial minimum investment than RLEFX: MRBPX (100) vs RLEFX (250). RLEFX annual gain was more profitable for investors over the last year : 12.30 vs. MRBPX (10.19). RLEFX return over 5 years is better than : 34.94 vs. MRBPX (16.39).
MRBPXRLEFXMRBPX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years9 years-
Gain YTD2.3353.12075%
Front LoadN/AN/A-
Min. Initial Investment10025040%
Min. Initial Investment IRAN/AN/A-
Net Assets1.64B241B1%
Annual Yield % from dividends2.312.4296%
Returns for 1 year10.1912.3083%
Returns for 3 years8.4715.2056%
Returns for 5 years16.3934.9447%
Returns for 10 years19.12N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPAR143.293.26
+2.33%
Interparfums Inc
ACGL94.580.76
+0.81%
Arch Capital Group Ltd
DSGN4.970.03
+0.61%
Design Therapeutics
GENI8.940.04
+0.45%
Genius Sports Limited
XLO0.69-0.02
-2.88%
Xilio Therapeutics